Discussion
In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting autoimmune diseases, potentially allowing some patients to avoid taking multiple immunosuppressive therapies simultaneously. The findings come from a review of eight adults in the French MS Registry (NCT02889965) who…